Related Experiment Video
Updated: Aug 8, 2025

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
Published on: February 23, 2024
Development of Nanoemulsions for Topical Application of Mupirocin
Bahjat Alhasso1, Muhammad Usman Ghori1, Barbara R Conway1,2
1Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.
Abstract:
Mupirocin (MUP) is a topical antibacterial agent used to treat superficial skin infections but has limited application due to in vivo inactivation and plasma protein binding. A nanoemulsion formulation has the potential to enhance the delivery of mupirocin into the skin. MUP-loaded nanoemulsions were prepared using eucalyptus oil (EO) or eucalyptol (EU), Tween® 80 (T80) and Span® 80 (S80) as oil phase (O), surfactant (S) and cosurfactant (CoS). The nanoemulsions were characterised and their potential to enhance delivery was assessed using an in vitro skin model. Optimised nanoemulsion formulations were prepared based on EO (MUP-NE EO) and EU (MUP-NE EU) separately. MUP-NE EO had a smaller size with mean droplet diameter of 35.89 ± 0.68 nm and narrower particle size index (PDI) 0.10 ± 0.02 nm compared to MUP-NE EU. Both nanoemulsion formulations were stable at 25 °C for three months with the ability to enhance the transdermal permeation of MUP as compared to the control, Bactroban® cream. Inclusion of EU led to a two-fold increase in permeation of MUP compared to the control, while EO increased the percentage by 48% compared to the control. Additionally, more MUP was detected in the skin after 8 h following MUP-NE EU application, although MUP deposition from MUP-NE EO was higher after 24 h. It may be possible, through choice of essential oil to design nanoformulations for both acute and prophylactic management of topical infections.
Insights
Nanoemulsions using eucalyptus oil or eucalyptol enhance topical delivery of the antibacterial mupirocin (MUP). These formulations show improved skin permeation and deposition, offering potential for managing skin infections.
Area of Science:
- Pharmaceutical Sciences
- Dermatology
- Nanotechnology
Background:
- Mupirocin (MUP) is a topical antibacterial agent for superficial skin infections.
- Limited application of MUP is due to in vivo inactivation and plasma protein binding.
- Nanoemulsion formulations can potentially enhance MUP delivery into the skin.
Purpose of the Study:
- To prepare and characterize MUP-loaded nanoemulsions using eucalyptus oil (EO) or eucalyptol (EU).
- To assess the potential of these nanoemulsions to enhance MUP skin delivery using an in vitro skin model.
- To compare the efficacy of EO and EU based nanoemulsions for MUP delivery.
Main Methods:
- MUP-loaded nanoemulsions were formulated using EO or EU as the oil phase, with Tween® 80 and Span® 80 as surfactant and cosurfactant.
- Nanoemulsions were characterized for droplet size and particle size index (PDI).
- In vitro skin permeation and deposition studies were conducted using an optimized skin model, comparing formulations to Bactroban® cream.
Main Results:
- Optimized nanoemulsions (MUP-NE EO and MUP-NE EU) were successfully prepared.
- MUP-NE EO exhibited smaller droplet size (35.89 ± 0.68 nm) and narrower PDI (0.10 ± 0.02) compared to MUP-NE EU.
- Both nanoemulsions enhanced MUP transdermal permeation; EU-based nanoemulsion showed a two-fold increase, while EO-based nanoemulsion increased permeation by 48% compared to the control.
- MUP-NE EU led to higher MUP detection in skin after 8 hours, whereas MUP-NE EO showed higher deposition after 24 hours.
Conclusions:
- Nanoemulsion formulations using eucalyptus oil or eucalyptol can effectively enhance the topical delivery of mupirocin.
- The choice of essential oil component (EO vs. EU) influences MUP permeation and skin deposition kinetics.
- These findings suggest the potential for designing tailored nanoformulations for acute and prophylactic management of topical infections.
More Related Videos
08:18Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022